{
    "2021-09-08": [
        [
            {
                "time": "",
                "original_text": "西南证券维持云南白药买入评级：聚焦主业，主营业务业绩大幅增长",
                "features": {
                    "keywords": [
                        "西南证券",
                        "云南白药",
                        "买入评级",
                        "聚焦主业",
                        "主营业务",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "云南白药(000538)：聚焦主业 主营业绩大幅增长",
                "features": {
                    "keywords": [
                        "云南白药",
                        "聚焦主业",
                        "主营业务",
                        "业绩增长"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "西南证券：维持云南白药(000538.SZ)“买入”评级 股权激励保障业绩 全年主营业务增长可期",
                "features": {
                    "keywords": [
                        "西南证券",
                        "云南白药",
                        "买入评级",
                        "股权激励",
                        "业绩保障",
                        "主营业务增长"
                    ],
                    "sentiment_score": 0.88,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "云南白药回应“股价下跌”",
                "features": {
                    "keywords": [
                        "云南白药",
                        "股价下跌"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}